List view / Grid view
29 May 2015 | By Victoria White
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease, including early-onset Alzheimer's disease...
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
28 May 2015 | By Victoria White
Researchers have found genetic evidence that dormant cancer cells can avoid the effects of treatment only to ‘wake up’ many years later...
28 May 2015 | By Victoria White
Scientists have identified an enzyme, LOX, that possibly holds the key to preventing secondary cancers in breast cancer patients...
27 May 2015 | By Victoria White
Merozyne has started a project to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy (MDC1A)...
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
26 May 2015 | By Oxford Global Conferences
In the run up to the Next Generation Sequencing USA Congress & co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences interviewed Ben Busby, Genomics Outreach Coordinator, NCBI...
26 May 2015 | By Victoria White
Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesising amines...
26 May 2015 | By Victoria White
In order to promote transparency in clinical trial data disclosure, Eisai is making its clinical trial data available to researchers via an external website...
22 May 2015 | By Victoria White
Vinpocetine is an effective treatment for middle-ear infections, showing the ability to improve bacterial clearance and reduce hearing loss...
22 May 2015 | By Victoria White
Achillion and Janssen have entered into a worldwide license and collaboration arrangement to develop and commercialise one or more of Achillion's HCV assets...
22 May 2015 | By Victoria White
Eureka Therapeutics and Boehringer Ingelheim have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology...
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
21 May 2015 | By Victoria White
Researchers have developed a second-generation of spectinomycin that shows early effectiveness against common bacterial infections...
21 May 2015 | By Victoria White
Alnylam has filed a Clinical Trial Application to initiate a Phase 1/2 clinical trial with ALN-AAT for the treatment of alpha-1 liver disease...
